What is Entosystem?
Entosystem operates at the intersection of biotechnology and agricultural innovation, utilizing proprietary insect farming processes to recover nutritional value from food waste. By converting organic materials into sustainable protein sources, the company provides a scalable solution for food safety and resource optimization. Its market position is defined by its commitment to the circular economy, where it serves as a critical link in the value chain for animal nutrition and agricultural inputs. Through its sophisticated production facilities, Entosystem ensures that waste streams are repurposed into high-value commodities, effectively reducing the environmental footprint of traditional food production systems.
How much funding has Entosystem raised?
Entosystem has raised a total of $58M across 1 funding round:
Other Financing Round
$58M
Other Financing Round (2024): $58M with participation from Idealist Capital, Fondaction, and Sanimax
Key Investors in Entosystem
Idealist Capital
A growth-oriented private equity firm that partners with entrepreneurs to scale proven economic solutions and reshape industries through high-conviction investing.
Fondaction
A Quebec-based investment fund focused on creating and maintaining quality jobs while fostering a stronger, more equitable, and greener economy.
Sanimax
A specialized BioReturn company that excels in rendering by-products into valuable agricultural and animal nutrition products.
What's next for Entosystem?
With the support of its latest strategic backers, Entosystem is poised to accelerate its operational expansion and enhance its technological infrastructure. The company is expected to focus on scaling its production capacity to meet the rising demand for sustainable protein alternatives in the animal feed and pet food markets. Furthermore, the strategic alignment with partners specializing in waste management and economic development suggests a long-term roadmap centered on regional market dominance and the refinement of its proprietary entomological processes. As the firm transitions into this next phase of growth, it will likely prioritize the optimization of its supply chain and the further integration of its circular economy model into broader industrial applications.
See full Entosystem company page
